165 related articles for article (PubMed ID: 2218653)
1. The absence of nephrotoxicity and differential nephrotoxicity between tobramycin and gentamicin.
Kepczyk T; Ryan PJ; McAllister K; Otraje J
South Med J; 1990 Oct; 83(10):1149-52. PubMed ID: 2218653
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of gentamicin and tobramycin on excretion of N-acetyl-beta-D-glucosaminidase.
Donta ST; Lembke LA
Antimicrob Agents Chemother; 1985 Oct; 28(4):500-3. PubMed ID: 4073872
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
[TBL] [Abstract][Full Text] [Related]
4. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
Matzke GR; Lucarotti RL; Shapiro HS
Am J Nephrol; 1983; 3(1):11-7. PubMed ID: 6340504
[TBL] [Abstract][Full Text] [Related]
5. Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycin.
Feig PU; Mitchell PP; Abrutyn E; Brock SM; Carney WR; Graeber CW; Horak E; Lyons RW; Maher JF
J Antimicrob Chemother; 1982 Sep; 10(3):217-26. PubMed ID: 6754682
[No Abstract] [Full Text] [Related]
6. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
Schentag JJ; Plaut ME; Cerra FB
Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates.
Gouyon JB; Aujard Y; Abisror A; Laudignon N; d'Athis P; Jacqz E; Biou D; Demelier JF; Mathieu H
Dev Pharmacol Ther; 1987; 10(2):145-52. PubMed ID: 3301233
[TBL] [Abstract][Full Text] [Related]
8. Tobramycin and amikacin nephrotoxicity. Value of serum creatinine versus urinary concentration of beta-2-microglobulin.
Gatell JM; SanMiguel JG; Zamora L; Araujo V; Castells C; Moreno A; Jimenez de Anta MT; Marin JL; Elena M; Ballesta A
Nephron; 1985; 41(4):337-43. PubMed ID: 3906418
[TBL] [Abstract][Full Text] [Related]
9. Gentamicin and tobramycin in patients with various infections--nephrotoxicity.
Kahlmeter G; Hallberg T; Kamme C
J Antimicrob Chemother; 1978 May; 4 Suppl A():47-52. PubMed ID: 659349
[No Abstract] [Full Text] [Related]
10. Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs.
Reiner NE; Bloxham DD; Thompson WL
J Antimicrob Chemother; 1978 May; 4 Suppl A():85-101. PubMed ID: 659354
[No Abstract] [Full Text] [Related]
11. Tobramycin and gentamicin are equally safe for neonates: results of a double-blind randomized trial with quantitative assessment of renal function.
Itsarayoungyuen S; Riff L; Schauf V; Hamilton L; Otrembiak J; Vidyasagar D
Pediatr Pharmacol (New York); 1982; 2(2):143-55. PubMed ID: 12760406
[TBL] [Abstract][Full Text] [Related]
12. Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis.
Tablan OC; Reyes MP; Rintelmann WF; Lerner AM
J Infect Dis; 1984 Feb; 149(2):257-63. PubMed ID: 6421944
[TBL] [Abstract][Full Text] [Related]
13. Is tobramycin less nephrotoxic than gentamicin?
Burkle WS
Clin Pharm; 1986 Jun; 5(6):514-6. PubMed ID: 3522055
[No Abstract] [Full Text] [Related]
14. Comparative cost effectiveness of gentamicin and tobramycin.
Holloway JJ; Smith CR; Moore RD; Feroli ER; Lietman PS
Ann Intern Med; 1984 Dec; 101(6):764-9. PubMed ID: 6437310
[TBL] [Abstract][Full Text] [Related]
15. Update on drug therapy: IX. Gentamicin and tobramycin nephrotoxicity.
Darr MS; Elenbaas JK
J Am Med Womens Assoc (1972); 1981 Oct; 36(10):310-6. PubMed ID: 7346536
[No Abstract] [Full Text] [Related]
16. Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study.
Kumin GD
JAMA; 1980 Oct; 244(16):1808-10. PubMed ID: 7420681
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin.
Gautier JC; Zhou X; Yang Y; Gury T; Qu Z; Palazzi X; Léonard JF; Slaoui M; Veeranagouda Y; Guizon I; Boitier E; Filali-Ansary A; van den Berg BHJ; Poetz O; Joos T; Zhang T; Wang J; Detilleux P; Li B
Toxicol Appl Pharmacol; 2016 Jul; 303():1-10. PubMed ID: 27105553
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin.
Gatell JM; SanMiguel JG; Araujo V; Zamora L; Maña J; Ferrer M; Bonet M; Bohe M; Jimenez de Anta MT
Antimicrob Agents Chemother; 1984 Nov; 26(5):766-9. PubMed ID: 6393868
[TBL] [Abstract][Full Text] [Related]
19. Urinary alanine aminopeptidase and beta 2-microglobulin as measurements of aminoglycoside-associated renal impairment.
Trollfors B; Bergmark J; Hiesche K; Jagenburg R
Infection; 1984; 12(1):20-2. PubMed ID: 6142864
[TBL] [Abstract][Full Text] [Related]
20. Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity.
Olsen KM; Rudis MI; Rebuck JA; Hara J; Gelmont D; Mehdian R; Nelson C; Rupp ME
Crit Care Med; 2004 Aug; 32(8):1678-82. PubMed ID: 15286543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
